GROWTH TRAJECTORY ON TRACK – RECORD $2 MILLION SALES WEEK
- Compumedics wins $1.125M (USD815K) contract to supply one of the US’s leading University Hospitals, in the state of Wisconsin with its sleep and neuro diagnostic equipment
- Compumedics wins $700K contract to supply prestigious Westmead Children’s Hospital in Sydney with its sleep and neuro diagnostic equipment
- Milestone achievement in creating another key reference site in the US for the Company’s neuro diagnostic product range, whilst continuing to build on the Company’s key strength in sleep diagnostics
- New contract re-enforces Compumedics’ strategy to expand its core business in major global medical device markets
Compumedics Limited (ASX: CMP) (“Compumedics” and “Company”) is pleased to announce that it has secured two major contracts to supply both its sleep and neuro diagnostic equipment to one of the US’s most prestigious University Hospitals, located in the state of Wisconsin and to the highly acclaimed Westmead Children’s Hospital in Sydney.
The contract wins are in line with the Company’s stated goal of growing its core businesses, including neuro diagnostics, into world markets, including the US and in particular states such as Wisconsin, where the Company has not had a significant market presence.
The winning of the contract in Sydney for the Westmead Children’s Hospital further validates Compumedics’ world leading credentials in both sleep and neuro diagnostics.
In commenting on Compumedics’ wins, Dr. David Burton, Chairman and CEO of Compumedics, said:
“Compumedics has spent almost thirty years building its global sleep and neurology diagnostic businesses and has spent more than a decade building its US business.
However, to-date the Company has a relatively small market share in neuro diagnostics. With this win and other Company activities in neuro diagnostics across the US the Company is committed to growing its presence in this large global market (USD1.3B).
With these key reference sites, Compumedics is well positioned to continue to grow its neuro diagnostic business in the US and around the world.
The Company is pleased these new contracts build strongly on our growing presence in the US and around the world, built from a loyal base of existing customers and staff.”
About Compumedics Limited
Compumedics Limited (ASX: CMP) is a medical device company involved in the development, manufacture and commercialisation of diagnostics technology for the sleep, brain and ultrasonic blood-flow monitoring applications. The Company owns US based Neuroscan and Germany based DWL Elektronishe GmbH. In conjunction with these two subsidiaries, Compumedics has a broad international reach, including Americas; Australia and Asia Pacific; and Europe and the Middle East.
Executive Chairman, Dr David Burton, founded Compumedics in 1987. In the same year the Company successfully designed and installed the first Australian, fully computerised Sleep Clinic at Epworth Hospital in Melbourne. Following this early success, Compumedics focused on the development of products that sold into the growing international sleep clinic and home monitoring markets. Compumedics listed on the Australian Securities Exchange in 2000. Over the years, Compumedics has received numerous awards and accolades including Australia’s exporter of the year and has been recognised as a Top 100 Innovator by both German and Australian Governments.
For further background please visit: www.compumedics.com
For further information please contact:
Dr David Burton,
Executive Chairman, CEO
T: + 61 3 8420 7300
Mr David Lawson,
Executive Director, CFO
T: + 61 3 8420 7300 F: +61 3 8420 7399
For investor relations and media enquiries please contact:
Bourse Communications Pty Ltd
T: (03) 9510 8309, M: 0408 670 706